Eiger BioPharmaceuticals ... (EIGR)
NASDAQ: EIGR
· Real-Time Price · USD
1.73
0.00 (0.29%)
At close: Apr 03, 2024, 3:59 PM
1.73
0.00%
After-hours: Jun 16, 2025, 04:00 PM EDT
Eiger BioPharmaceuticals Revenue Breakdown
| Period Ending | Dec 31, 2022 |
|---|---|
| Other Revenue Revenue | 750K |
| Other Revenue Revenue Growth | n/a |
| Product Revenue | 12.73M |
| Product Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.7M | 5.45M | 5.53M | 9.52M | 8.3M | 6.96M | 7.03M | 6.81M | 5.98M | 6.47M | 5.89M | 5.56M | 5.42M | 5.03M | 4.87M | 5.24M | 4.58M | 4.25M | 4.22M | 4.06M | 4.08M | 3.64M | 3.24M | 2.99M | 2.81M | 2.73M | 2.95M | 3.52M | 3.53M | 3.26M | 2.48M | 3.83M | 1.63M | 2.53M | 3.49M | 4.78M |
| Selling, General, and Administrative Revenue Growth | -13.79% | -1.43% | -41.85% | +14.62% | +19.20% | -0.90% | +3.14% | +13.85% | -7.45% | +9.85% | +5.79% | +2.69% | +7.78% | +3.16% | -7.02% | +14.33% | +7.94% | +0.52% | +4.14% | -0.61% | +12.05% | +12.54% | +8.12% | +6.70% | +2.90% | -7.43% | -16.35% | -0.28% | +8.21% | +31.77% | -35.38% | +135.15% | -35.65% | -27.48% | -26.91% | n/a |
| Research and Development Revenue | 11.61M | 14.57M | 19.4M | 16.75M | 18.52M | 22.2M | 16.99M | 17.57M | 18.19M | 18.11M | 14.3M | 13.84M | 12.54M | 9.81M | 9.75M | 9.48M | 11.93M | 14.06M | 12.94M | 12.87M | 12.01M | 13.2M | 6.37M | 5.51M | 7.78M | 6.14M | 8.13M | 7.46M | 9.38M | 8.07M | 10.72M | 4.84M | 202K | 738K | 9.5M | 11.52M |
| Research and Development Revenue Growth | -20.28% | -24.91% | +15.84% | -9.57% | -16.56% | +30.63% | -3.28% | -3.39% | +0.44% | +26.60% | +3.32% | +10.34% | +27.88% | +0.57% | +2.88% | -20.51% | -15.16% | +8.68% | +0.53% | +7.14% | -8.98% | +107.09% | +15.60% | -29.14% | +26.59% | -24.43% | +8.94% | -20.40% | +16.17% | -24.70% | +121.26% | +2298.51% | -72.63% | -92.23% | -17.51% | n/a |